Rifampicin dramatically decreases clindamycin plasma concentrations in patients treated for bone/joint infections

被引：0
|
作者：
Venisse, N. [1 ]
Le Moal, G. [1 ]
Sury-Lestage, S. [1 ]
Beraud, G. [1 ]
机构：
[1] CHU Poitiers, Poitiers, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2014年 / 28卷
关键词：
clindamycin; rifampicin; drug-drug interaction; pharmacokinetics; therapeutic drug monitoring;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections
    Emmanuel Curis
    Vincent Pestre
    Vincent Jullien
    Luc Eyrolle
    Denis Archambeau
    Philippe Morand
    Laure Gatin
    Matthieu Karoubi
    Nicolas Pinar
    Valérie Dumaine
    Jean-Claude Nguyen Van
    Antoine Babinet
    Philippe Anract
    Dominique Salmon
    [J]. Infection, 2015, 43 : 473 - 481
  • [2] Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections
    Curis, Emmanuel
    Pestre, Vincent
    Jullien, Vincent
    Eyrolle, Luc
    Archambeau, Denis
    Morand, Philippe
    Gatin, Laure
    Karoubi, Matthieu
    Pinar, Nicolas
    Dumaine, Valerie
    Van, Jean-Claude Nguyen
    Babinet, Antoine
    Anract, Philippe
    Salmon, Dominique
    [J]. INFECTION, 2015, 43 (04) : 473 - 481
  • [3] Bone and joint infections: Risk of clindamycin low concentration when combined with rifampicin
    Valour, F.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2015, 45 (08): : 343 - 343
  • [4] CLINDAMYCIN IN BONE AND JOINT INFECTIONS
    GEDDES, AM
    DWYER, NSJ
    BALL, AP
    AMOS, RS
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1977, 3 (05) : 501 - 507
  • [5] Rifampicin decreases plasma buspirone concentrations
    [J]. Reactions Weekly, 1998, 698 (1) : 4 - 4
  • [6] Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections
    Guillaume, M.
    Garraffo, R.
    Bensalem, M.
    Janssen, C.
    Bland, S.
    Gaillat, J.
    Bru, J. -P.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (09): : 414 - 420
  • [7] Safety of linezolid, rifampicin, and clindamycin combination therapy in patients with prosthetic joint infection
    Kobayashi, Shunsuke
    Tagawa, Seiji
    Ogura, Takashi
    Kitaoka, Akira
    Yasu, Takeo
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (03): : 142 - 144
  • [8] Continuous Clindamycin Infusion, an Innovative Approach to Treating Bone and Joint Infections
    Zeller, Valerie
    Dzeing-Ella, Arnaud
    Kitzis, Marie-Dominique
    Ziza, Jean-Marc
    Mamoudy, Patrick
    Desplaces, Nicole
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 88 - 92
  • [9] Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections
    Hoyo, Irma
    Martinez-Pastor, Juan
    Garcia-Ramiro, Sebastian
    Climent, Consuelo
    Brunet, Merce
    Cuesta, Marta
    Mensa, Josep
    Soriano, Alex
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (07) : 548 - 550
  • [10] Treatment of prosthetic joint infections due to Propionibacterium Similar results in 60 patients treated with and without rifampicin
    Jacobs, Anouk M. E.
    Van Hooff, Miranda L.
    Meis, Jacques F.
    Vos, Fidel
    Goosen, Jon H. M.
    [J]. ACTA ORTHOPAEDICA, 2016, 87 (01) : 60 - 66
12345